Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
153.89
135.96
168.15
119.86
148.50
144.42
243.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
153.89
135.96
168.15
119.86
148.50
144.42
243.52
Raw Material Cost
62.56
80.20
104.17
75.46
115.61
62.60
88.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
67.67
33.10
25.84
34.12
48.29
44.13
27.80
Other Expenses
2.24
2.10
2.62
4.62
3.71
2.67
2.54
Total Expenditure (Excl Depreciation)
152.67
134.27
156.21
155.82
200.97
133.44
141.94
Operating Profit (PBDIT) excl Other Income
1.2
1.7000000000000002
11.899999999999999
-36
-52.5
11
101.6
Other Income
4.68
4.62
10.55
-19.48
0.93
10.79
13.63
Operating Profit (PBDIT)
4.99
45.06
63.85
-19.22
-12.99
58.44
151.88
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
17.61
84.53
25.52
-50.63
-3.17
-74.45
-44.05
Gross Profit (PBDT)
91.33
55.76
63.98
44.40
32.88
81.82
154.78
Depreciation
0.00
41.35
41.35
39.49
39.49
36.67
36.67
Profit Before Tax
22.60
88.24
48.02
-109.34
-55.65
-52.68
71.16
Tax
2.59
13.23
2.41
-39.04
-9.12
-11.78
1.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.05
75.08
45.97
-57.33
-46.33
-40.54
70.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.05
75.08
45.97
-57.33
-46.33
-40.54
70.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.04
-0.07
-0.35
-0.21
-0.20
-0.35
-0.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.01
75.01
45.62
-57.54
-46.53
-40.89
69.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,693.00
5,693.50
5,618.42
5,572.45
5,629.78
5,830.21
5,870.75
Earnings per share (EPS)
0.02
0.07
0.04
-0.06
-0.05
-0.04
0.07
Diluted Earnings per share
0.02
0.07
0.04
-0.06
-0.05
-0.04
0.07
Operating Profit Margin (Excl OI)
0.2%
-0.67%
7.1%
-32.73%
-35.97%
7.61%
41.71%
Gross Profit Margin
14.69%
95.31%
53.15%
-58.28%
-10.88%
-11.08%
44.28%
PAT Margin
13.03%
55.22%
27.34%
-47.83%
-31.2%
-28.07%
28.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 3.64% vs -22.74% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 143.01% vs 0.00% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 102.16% vs -139.71% in Sep 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Beijing SL Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
153.89
0
153.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
153.89
0
153.89
Raw Material Cost
62.56
0
62.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
67.67
0
67.67
Other Expenses
2.24
0.00
2.24
Total Expenditure (Excl Depreciation)
152.67
0
152.67
Operating Profit (PBDIT) excl Other Income
1.22
0.00
1.22
Other Income
4.68
0
4.68
Operating Profit (PBDIT)
4.99
0
4.99
Interest
0.00
0
0.00
Exceptional Items
17.61
0
17.61
Gross Profit (PBDT)
91.33
0
91.33
Depreciation
0.00
0
0.00
Profit Before Tax
22.60
0
22.60
Tax
2.59
0
2.59
Provisions and contingencies
0
0
0.00
Profit After Tax
20.05
0
20.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.05
0
20.05
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.04
0
-0.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.01
0
20.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,693.00
0
5,693.00
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
0.20%
0%
0.00
0.20%
Gross Profit Margin
14.69%
0%
0.00
14.69%
PAT Margin
13.03%
0%
0.00
13.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15.39 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 13.16% vs -19.14% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.64% vs -22.74% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.00 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -73.33% vs 64.47% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 143.01% vs 0.00% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.03 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -99.26% vs -24.20% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 102.16% vs -139.71% in Sep 2024
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.20%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
